IN2014CN04470A - - Google Patents
Download PDFInfo
- Publication number
- IN2014CN04470A IN2014CN04470A IN4470CHN2014A IN2014CN04470A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A IN 4470CHN2014 A IN4470CHN2014 A IN 4470CHN2014A IN 2014CN04470 A IN2014CN04470 A IN 2014CN04470A
- Authority
- IN
- India
- Prior art keywords
- ketoreductase polypeptides
- preparation
- present disclosure
- making
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/001—Amines; Imines
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/02—Amides, e.g. chloramphenicol or polyamides; Imides or polyimides; Urethanes, i.e. compounds comprising N-C=O structural element or polyurethanes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/002—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by oxidation/reduction reactions
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01184—Carbonyl reductase (NADPH) (1.1.1.184)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P20/00—Technologies relating to chemical industry
- Y02P20/50—Improvements relating to the production of bulk chemicals
- Y02P20/52—Improvements relating to the production of bulk chemicals using catalysts, e.g. selective catalysts
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Analytical Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
The present disclosure relates to engineered ketoreductase polypeptides for the preparation of hydroxyl substituted carbamate compounds and polynucleotides vectors host cells and methods of making and using the ketoreductase polypeptides.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201161561665P | 2011-11-18 | 2011-11-18 | |
PCT/US2012/065046 WO2013074650A1 (en) | 2011-11-18 | 2012-11-14 | Biocatalysts for the preparation of hydroxy substituted carbamates |
Publications (1)
Publication Number | Publication Date |
---|---|
IN2014CN04470A true IN2014CN04470A (en) | 2015-09-04 |
Family
ID=47295185
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IN4470CHN2014 IN2014CN04470A (en) | 2011-11-18 | 2012-11-14 |
Country Status (8)
Country | Link |
---|---|
US (8) | US9139819B2 (en) |
EP (1) | EP2780448B1 (en) |
CN (2) | CN104053771B (en) |
HU (1) | HUE046089T2 (en) |
IL (1) | IL232621B (en) |
IN (1) | IN2014CN04470A (en) |
SG (1) | SG11201402401TA (en) |
WO (1) | WO2013074650A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7977078B2 (en) | 2007-08-24 | 2011-07-12 | Codexis, Inc. | Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane |
JP6088535B2 (en) | 2011-10-27 | 2017-03-08 | メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. | Process for producing beta 3 agonists and intermediates |
EP2770996B1 (en) | 2011-10-27 | 2016-09-28 | Merck Sharp & Dohme Corp. | Process for making beta 3 agonists and intermediates |
WO2013074650A1 (en) | 2011-11-18 | 2013-05-23 | Codexis, Inc. | Biocatalysts for the preparation of hydroxy substituted carbamates |
WO2014150633A1 (en) * | 2013-03-15 | 2014-09-25 | Merck Sharp & Dohme Corp. | Immobilized ketoreductases and process for making and using immobilized ketoreductase |
HUE045260T2 (en) * | 2013-03-15 | 2019-12-30 | Merck Sharp & Dohme | Process for preparing beta 3 agonists and intermediates |
EP3256577B1 (en) * | 2015-02-10 | 2020-08-26 | Codexis, Inc. | Ketoreductase polypeptides for the synthesis of chiral compounds |
CN106011095B (en) * | 2016-07-27 | 2021-02-26 | 苏州汉酶生物技术有限公司 | Engineered ketoreductase polypeptide and method for preparing ezetimibe intermediate by using same |
CN109943543B (en) * | 2019-03-28 | 2020-12-11 | 上海健康医学院 | Alcohol dehydrogenase mutant and preparation method and application thereof |
CN114410599B (en) * | 2022-01-29 | 2023-08-18 | 浙江工业大学 | Carbonyl reductase mutant and application thereof in preparation of rosuvastatin chiral intermediate |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5538867A (en) | 1988-09-13 | 1996-07-23 | Elf Aquitaine | Process for the electrochemical regeneration of pyridine cofactors |
JP3155107B2 (en) | 1993-01-12 | 2001-04-09 | ダイセル化学工業株式会社 | Method for producing optically active 4-halo-3-hydroxybutyrate |
US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
US6335160B1 (en) | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
CN1087725C (en) | 1994-03-25 | 2002-07-17 | 同位素技术有限公司 | Enhancement of the effect of drugs by deuteration |
JPH08336393A (en) | 1995-04-13 | 1996-12-24 | Mitsubishi Chem Corp | Production of optically active gamma-substituted-beta-hydroxybutyric ester |
FI104465B (en) | 1995-06-14 | 2000-02-15 | Valio Oy | Protein hydrolyzates for the treatment and prevention of allergies and their preparation and use |
US5891685A (en) | 1996-06-03 | 1999-04-06 | Mitsubishi Chemical Corporation | Method for producing ester of (S)-γ-halogenated-β-hydroxybutyric acid |
US6342507B1 (en) | 1997-09-05 | 2002-01-29 | Isotechnika, Inc. | Deuterated rapamycin compounds, method and uses thereof |
WO1999018120A1 (en) | 1997-10-08 | 1999-04-15 | Isotechnika Inc. | Deuterated cyclosporine analogs and their use as immunomodulating agents |
IL136574A0 (en) | 1997-12-08 | 2001-06-14 | California Inst Of Techn | A method for forming a polynucleotide of desired properties |
US6495023B1 (en) | 1998-07-09 | 2002-12-17 | Michigan State University | Electrochemical methods for generation of a biological proton motive force and pyridine nucleotide cofactor regeneration |
DE19857302C2 (en) | 1998-12-14 | 2000-10-26 | Forschungszentrum Juelich Gmbh | Process for the enantioselective reduction of 3,5-dioxocarboxylic acids, their salts and esters |
JP4221100B2 (en) | 1999-01-13 | 2009-02-12 | エルピーダメモリ株式会社 | Semiconductor device |
US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
AU3874900A (en) | 1999-03-11 | 2000-09-28 | Eastman Chemical Company | Enzymatic reductions with dihydrogen via metal catalyzed cofactor regeneration |
SI20642A (en) | 1999-12-03 | 2002-02-28 | Kaneka Corporation | Novel carbonyl reductase, gene thereof and method of using the same |
WO2001075767A2 (en) | 2000-03-30 | 2001-10-11 | Maxygen, Inc. | In silico cross-over site selection |
US6800477B2 (en) | 2001-03-22 | 2004-10-05 | Bristol-Myers Squibb Co. | Stereoselective reduction of substituted acetophenone |
US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
MXPA06001719A (en) | 2003-08-11 | 2006-05-19 | Codexis Inc | Improved glucose dehydrogenase polypeptides and related polynucleotides. |
BRPI0413501A (en) | 2003-08-11 | 2006-10-10 | Codexis Inc | polypeptide, isolated or recombinant polynucleotide, expression vector, host cell, and method of preparing an hhdh polypeptide |
JP2007502124A (en) | 2003-08-11 | 2007-02-08 | コデクシス, インコーポレイテッド | Improved ketoreductase polypeptides and related polynucleotides |
AU2004266100A1 (en) | 2003-08-11 | 2005-03-03 | Codexis, Inc. | Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters |
EP1712633A1 (en) | 2003-12-02 | 2006-10-18 | Mercian Corporation | Process for producing optically active tetrahydrothiophene derivative and method of crystallizing optically active tetrahydrothiophen-3-ol |
US7705036B2 (en) | 2004-04-01 | 2010-04-27 | Cardiome Pharma Corp. | Deuterated aminocyclohexyl ether compounds and processes for preparing same |
US7393667B2 (en) | 2005-05-31 | 2008-07-01 | Bristol-Myers Squibb Company | Stereoselective reduction process for the preparation of pyrrolotriazine compounds |
WO2008103248A1 (en) * | 2007-02-08 | 2008-08-28 | Codexis, Inc. | Ketoreductases and uses thereof |
US20090118130A1 (en) | 2007-02-12 | 2009-05-07 | Codexis, Inc. | Structure-activity relationships |
US7977078B2 (en) | 2007-08-24 | 2011-07-12 | Codexis, Inc. | Ketoreductase polypeptides for the production of (R)-3-hydroxythiolane |
KR101586503B1 (en) | 2007-09-13 | 2016-01-18 | 코덱시스, 인코포레이티드 | Ketoreductase polypeptides for the reduction of acetophenones |
KR20100061571A (en) | 2007-09-28 | 2010-06-07 | 코덱시스, 인코포레이티드 | Ketoreductase polypeptides and uses thereof |
HUE027683T2 (en) | 2007-10-01 | 2016-10-28 | Codexis Inc | Ketoreductase polypeptides for the production of azetidinone |
PE20091825A1 (en) | 2008-04-04 | 2009-12-04 | Merck & Co Inc | HYDROXIMETHYL PYRROLIDINES AS AGONISTS OF THE BETA 3 ADRENERGIC RECEPTOR |
US20090312196A1 (en) | 2008-06-13 | 2009-12-17 | Codexis, Inc. | Method of synthesizing polynucleotide variants |
US8288131B2 (en) | 2008-08-27 | 2012-10-16 | Codexis, Inc. | Ketoreductase polypeptides and uses thereof |
ES2560459T3 (en) | 2008-08-27 | 2016-02-19 | Codexis, Inc. | Cetorreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
US8288141B2 (en) | 2008-08-27 | 2012-10-16 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
EP2329014B1 (en) * | 2008-08-29 | 2014-10-22 | Codexis, Inc. | Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
SG178456A1 (en) | 2009-08-19 | 2012-04-27 | Codexis Inc | Ketoreductase polypeptides for the preparation of phenylephrine |
WO2011140219A1 (en) | 2010-05-04 | 2011-11-10 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
WO2013074650A1 (en) | 2011-11-18 | 2013-05-23 | Codexis, Inc. | Biocatalysts for the preparation of hydroxy substituted carbamates |
-
2012
- 2012-11-14 WO PCT/US2012/065046 patent/WO2013074650A1/en active Application Filing
- 2012-11-14 SG SG11201402401TA patent/SG11201402401TA/en unknown
- 2012-11-14 US US14/357,964 patent/US9139819B2/en active Active
- 2012-11-14 EP EP12795954.2A patent/EP2780448B1/en active Active
- 2012-11-14 IN IN4470CHN2014 patent/IN2014CN04470A/en unknown
- 2012-11-14 CN CN201280067329.9A patent/CN104053771B/en active Active
- 2012-11-14 HU HUE12795954A patent/HUE046089T2/en unknown
- 2012-11-14 CN CN201610911937.3A patent/CN106479990B/en active Active
-
2014
- 2014-05-14 IL IL23262114A patent/IL232621B/en active IP Right Grant
-
2015
- 2015-08-13 US US14/825,688 patent/US9422531B2/en active Active
-
2016
- 2016-07-15 US US15/211,990 patent/US9803178B2/en active Active
-
2017
- 2017-09-21 US US15/711,119 patent/US10100287B2/en active Active
-
2018
- 2018-09-10 US US16/126,044 patent/US10253303B2/en active Active
-
2019
- 2019-02-25 US US16/284,235 patent/US10851351B2/en active Active
-
2020
- 2020-10-29 US US17/084,405 patent/US11713451B2/en active Active
-
2023
- 2023-06-12 US US18/333,393 patent/US20240018489A1/en active Pending
Also Published As
Publication number | Publication date |
---|---|
US9139819B2 (en) | 2015-09-22 |
SG11201402401TA (en) | 2014-06-27 |
US20160319247A1 (en) | 2016-11-03 |
US11713451B2 (en) | 2023-08-01 |
US20140322769A1 (en) | 2014-10-30 |
HUE046089T2 (en) | 2020-01-28 |
US10851351B2 (en) | 2020-12-01 |
CN104053771B (en) | 2016-11-09 |
CN106479990A (en) | 2017-03-08 |
US20150344850A1 (en) | 2015-12-03 |
WO2013074650A1 (en) | 2013-05-23 |
US20180371427A1 (en) | 2018-12-27 |
US20180010100A1 (en) | 2018-01-11 |
EP2780448A1 (en) | 2014-09-24 |
EP2780448B1 (en) | 2019-09-11 |
IL232621A0 (en) | 2014-06-30 |
US10100287B2 (en) | 2018-10-16 |
CN106479990B (en) | 2020-09-18 |
US20240018489A1 (en) | 2024-01-18 |
US9422531B2 (en) | 2016-08-23 |
US20210071151A1 (en) | 2021-03-11 |
US10253303B2 (en) | 2019-04-09 |
US20190177702A1 (en) | 2019-06-13 |
IL232621B (en) | 2019-10-31 |
CN104053771A (en) | 2014-09-17 |
US9803178B2 (en) | 2017-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IN2014CN04470A (en) | ||
ZA201502433B (en) | Methods of host cell modification | |
IL231171A0 (en) | Rna engineered t cells for the treatment of cancer | |
AP3964A (en) | Methods of processing lignocellulosic biomass | |
IN2014CN04586A (en) | ||
MX2013007853A (en) | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same. | |
MX337919B (en) | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same. | |
PL3070170T3 (en) | Fermentation of co2 by using an electrical potential | |
MX337913B (en) | Polypeptides having cellobiohydrolase activity and polynucleotides encoding same. | |
MX355356B (en) | Alpha-amylase variants and polynucleotides encoding same. | |
SG10201510009YA (en) | Methods of metabolic targeting cancer cells using chemo- and immunotherapy for treating cancer | |
MX2014004539A (en) | Alpha-amylase variants and polynucleotides encoding same. | |
ZA201504408B (en) | Solution formulations of engineered anti-il-23p19 antibodies | |
EP2912166A4 (en) | Methods of producing pluripotent stem cells from chondrocytes | |
EP2832848A4 (en) | Culture medium for proliferating stem cell, which contains sulfated compound | |
MX2014001594A (en) | Polypeptides having cellulase activity and polynucleotides encoding same. | |
EP2831234A4 (en) | Compositions, methods, and plant genes for the improved production of fermentable sugars for biofuel production | |
EP2916878A4 (en) | Triggerable compositions for two-stage, controlled release of active chemistry | |
ZA201403104B (en) | Process for the preparation of higher alcohols | |
WO2013011062A3 (en) | Antagonistic antibodies against oscar | |
MY166897A (en) | Stable compositions and methods for preparing the same | |
IL229242B (en) | Allogeneic tumor cell vaccination | |
AU2012905250A0 (en) | Uses of Bacopa monnieri extract | |
GB201219906D0 (en) | Matrix binders, uses & methods of manufacture | |
AU2011902709A0 (en) | Process for the extraction of galactooligosaccharide |